Murphy Andrew J's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Dec 6, 2023
- Accession no.
- 0001968202-23-000046
- Filed
- Dec 6, 2023
- Trade date
- Dec 4-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.34M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murphy Andrew JCIK 0001796226 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $270.43 | +$5,408,600 | 79,421 | Direct | |
| Dec 4, 2023 | Common Stock | FTax withholdingDisposed | −13,464 | $813.58 | −$10,954,041.12 | 65,957 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −136 | $810.38 | −$110,211.68 | 65,821 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −103 | $811.37 | −$83,571.11 | 65,718 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −372 | $812.57F2 | −$302,276.04 | 65,346 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −167 | $813.66F3 | −$135,881.22 | 65,179 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −58 | $814.06 | −$47,215.48 | 65,121 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −155 | $815.97F4 | −$126,475.35 | 64,966 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −829 | $816.46F5 | −$676,845.34 | 64,137 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −1,881 | $817.36F6 | −$1,537,454.16 | 62,256 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −1,333 | $818.59F7 | −$1,091,180.47 | 60,923 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −973 | $819.57F8 | −$797,441.61 | 59,950 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −345 | $820.54F9 | −$283,086.3 | 59,605 | Direct | |
| Dec 5, 2023 | Common Stock | SSaleDisposed | −184 | $821.46F10 | −$151,148.64 | 59,421 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 372 shares of Company stock on December 5, 2023 at prices ranging from $812.26 to $812.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 167 shares of Company stock on December 5, 2023 at prices ranging from $813.00 to $813.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 155 shares of Company stock on December 5, 2023 at prices ranging from $815.90 to $815.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 829 shares of Company stock on December 5, 2023 at prices ranging from $816.01 to $816.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 1,881 shares of Company stock on December 5, 2023 at prices ranging from $817.04 to $817.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 1,333 shares of Company stock on December 5, 2023 at prices ranging from $818.07 to $818.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 973 shares of Company stock on December 5, 2023 at prices ranging from $819.03 to $819.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 345 shares of Company stock on December 5, 2023 at prices ranging from $820.27 to $820.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 184 shares of Company stock on December 5, 2023 at prices ranging from $821.39 to $821.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 5, 2023 at each separate price.
Referenced by the price of 1 transaction in Table I.